NOVO INTEGRATED SCIENCES INC (NVOS)

US67011T3005 - Common Stock

0.15  -0.02 (-13.29%)

After market: 0.1132 -0.04 (-24.53%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023
Revenue
YoY % growth
9.31M
18.45%
11.74M
26.10%
12.572M
7.09%
EBITDA
YoY % growth
-2.55M
8.60%
-6.57M
-157.65%
-6.25M
4.86%
EBIT
YoY % growth
-4.27M
-0.71%
-9.59M
-124.59%
-8.553M
10.81%
Operating Margin
-45.86%-81.69%-68.03%
EPS
YoY % growth
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
3.152M
-4.20%
%
Q2 2024
Q2Q % growth
3.171M
23.85%
%
Q1 2024
Q2Q % growth
3.891M
13.78%
%
Q4 2023
Q2Q % growth
3.303M
140.53%
%
Q3 2023
Q2Q % growth
3.29M
-76.25%
%
Q2 2023
Q2Q % growth
2.56M
-10.80%
%
Q1 2023
Q2Q % growth
3.42M
8.23%
%
Q4 2022
Q2Q % growth
-8.15M
-402.97%
%
Q3 2022
Q2Q % growth
13.85M
481.93%
%
Q2 2022
Q2Q % growth
2.87M
37.98%
%
Q1 2022
Q2Q % growth
3.16M
46.30%
%
Q4 2021
Q2Q % growth
2.69M
46.20%
%
Q3 2021
Q2Q % growth
2.38M
128.85%
%
Q2 2021
Q2Q % growth
2.08M
-14.40%
%
Q1 2021
Q2Q % growth
2.16M
-15.29%
%
Q4 2020
Q2Q % growth
1.84M
-23.97%
%
Q3 2020
Q2Q % growth
1.04M
-58.23%
%
Q2 2020
Q2Q % growth
2.43M
10.45%
%
Q1 2020
Q2Q % growth
2.55M
10.39%
%
Q4 2019
Q2Q % growth
2.42M
11.52%
%
Q3 2019
Q2Q % growth
2.49M
7.33%
%
Q2 2019
Q2Q % growth
2.2M
2.33%
%
Q1 2019
Q2Q % growth
2.31M
2.67%
%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A